Trending Stocks: General Motors Company (NYSE:GM), Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), Cowen Group, Inc. (NASDAQ:COWN), Amicus Therapeutics, Inc. (NASDAQ:FOLD)

General Motors Company (NYSE:GM) said that, it plans to build a new, 883,000-square-foot body shop for Flint Assembly, which makes full-size pickups for the Chevrolet and GMC brands. General Motors Company (NYSE:GM) belongs to Consumer Goods sector. Its net profit margin is 3.00% and weekly performance is 0.64%. On last trading day company shares ended up $31.52. General Motors Company (NYSE:GM) distance from 50-day simple moving average (SMA50) is -6.13%.

On 27 July, Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) announced that Aegerion board member Sandford Drexel Smith has been appointed interim Chief Executive Officer of the Company. Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) shares decreased -0.31% in last trading session and ended the day at $19.52. AEGR Gross Margin is 87.70% and its return on assets is -11.30%. Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) quarterly performance is -10.21%.

On 30 July, Cowen Group, Inc. (NASDAQ:COWN) announced its operating results for the second quarter ended June 30, 2015. For the second quarter of 2015, the Company reported GAAP net income attributable to common shareholders of $6.0 million, or $0.05 per diluted share, as compared to GAAP net income attributable to common shareholders of $8.4 million, or $0.07 per diluted share, in the second quarter of 2014. On 04 August, Cowen Group, Inc. (NASDAQ:COWN) shares decreased -1.56% and was closed at $5.68. COWN EPS growth in last 5 year was 24.90%. Cowen Group, Inc. (NASDAQ:COWN) year to date (YTD) performance is 18.33%.

Amicus Therapeutics, Inc. (NASDAQ:FOLD) announced a conference call and live audio webcast on Wednesday, August 5, 2015 at 5:00 p.m. ET to discuss financial results for the second quarter ended June 30, 2015.Amicus Therapeutics, Inc. (NASDAQ:FOLD) ended the last trading day at $18.02. Company weekly volatility is calculated as 3.77% and price to cash ratio as 13.74. Amicus Therapeutics, Inc. (NASDAQ:FOLD) showed a weekly performance of 9.34%.

Leave a Reply

Your email address will not be published. Required fields are marked *